|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06955 BOAN BIOTECH
Nominal 
9.240 +0.130 (+1.427%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (18,568) | (201,841) | (246,278) | (506,720) |
| Net Cash from / (used in) Investing Activities | -- | (293,571) | (100,684) | (432,296) | (18,787) |
| Net Cash from / (used in) Financing Activities | -- | 283,086 | (127) | 1,211,729 | 527,233 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (29,053) | (302,652) | 533,155 | 1,726 |
| Cash & Cash Equivalents at beginning of period | -- | 233,498 | 531,703 | 3,629 | 1,903 |
| Effect of Foreign Exchange Rate Changes | -- | (2,595) | 4,447 | (5,081) | 0 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 201,850 | 233,498 | 531,703 | 3,629 |
| Remarks: | Real time quote last updated: 01/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 61,672,000 |
| %Change | -- |
| EPS / (LPS) | RMB 0.120 |
| NBV Per Share (¥) | RMB 2.733 |